Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1217122.RAlObBzQByvE_fIJ0DazrO1ypQqvnoXIvq8plvvgpScno130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1217122.RAlObBzQByvE_fIJ0DazrO1ypQqvnoXIvq8plvvgpScno130_assertion type Assertion NP1217122.RAlObBzQByvE_fIJ0DazrO1ypQqvnoXIvq8plvvgpScno130_head.
- NP1217122.RAlObBzQByvE_fIJ0DazrO1ypQqvnoXIvq8plvvgpScno130_assertion description "[Our study showed that serum miRNAs 21 and 221 expression profiling tests may be used as specific noninvasive molecular biomarkers for prostate cancer diagnosis due to their higher sensitivity and specificity with a high negative predictive value leading to a decrease in the biopsies taken for patients with elevated serum PSA values.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1217122.RAlObBzQByvE_fIJ0DazrO1ypQqvnoXIvq8plvvgpScno130_provenance.
- NP1217122.RAlObBzQByvE_fIJ0DazrO1ypQqvnoXIvq8plvvgpScno130_assertion evidence source_evidence_literature NP1217122.RAlObBzQByvE_fIJ0DazrO1ypQqvnoXIvq8plvvgpScno130_provenance.
- NP1217122.RAlObBzQByvE_fIJ0DazrO1ypQqvnoXIvq8plvvgpScno130_assertion SIO_000772 25190021 NP1217122.RAlObBzQByvE_fIJ0DazrO1ypQqvnoXIvq8plvvgpScno130_provenance.
- NP1217122.RAlObBzQByvE_fIJ0DazrO1ypQqvnoXIvq8plvvgpScno130_assertion wasDerivedFrom befree-2016 NP1217122.RAlObBzQByvE_fIJ0DazrO1ypQqvnoXIvq8plvvgpScno130_provenance.
- NP1217122.RAlObBzQByvE_fIJ0DazrO1ypQqvnoXIvq8plvvgpScno130_assertion wasGeneratedBy ECO_0000203 NP1217122.RAlObBzQByvE_fIJ0DazrO1ypQqvnoXIvq8plvvgpScno130_provenance.